Inactive Ingredient Search for Approved Drug Products

Latest News: FDA announced upcoming changes to the Inactive Ingredient Database: more information

About this Database | Back to Search Page

SRS | Guidances | CFR

Search Names Beginning with X

Inactive Ingredient	Route	Dosage Form	CAS Number	UNII	Maximum Potency per unit dose	Record Updated
XANTHAN GUM	OPHTHALMIC	SOLUTION	11138662	TTV12P4NEE	0.6%w/v
XANTHAN GUM	OPHTHALMIC	SOLUTION, GEL FORMING, EXTENDED RELEASE	11138662	TTV12P4NEE	0.6%w/w
XANTHAN GUM	OPHTHALMIC	SUSPENSION	11138662	TTV12P4NEE	0.6%w/w
XANTHAN GUM	ORAL	CAPSULE	11138662	TTV12P4NEE	0.01mg
XANTHAN GUM	ORAL	CAPSULE, EXTENDED RELEASE	11138662	TTV12P4NEE	0.16mg
XANTHAN GUM	ORAL	FILM, SOLUBLE	11138662	TTV12P4NEE	0.3mg
XANTHAN GUM	ORAL	GRANULE, FOR SUSPENSION	11138662	TTV12P4NEE	75mg	Y
XANTHAN GUM	ORAL	LIQUID, EXTENDED RELEASE	11138662	TTV12P4NEE	4.17mg/1ml
XANTHAN GUM	ORAL	LOZENGE	11138662	TTV12P4NEE	50mg
XANTHAN GUM	ORAL	PASTE	11138662	TTV12P4NEE	8050mg/230ml
XANTHAN GUM	ORAL	POWDER	11138662	TTV12P4NEE	0.01mg/mg
XANTHAN GUM	ORAL	POWDER, FOR SOLUTION	11138662	TTV12P4NEE	10mg/5ml
XANTHAN GUM	ORAL	POWDER, FOR SUSPENSION	11138662	TTV12P4NEE	360.13mg	Y
XANTHAN GUM	ORAL	SOLUTION	11138662	TTV12P4NEE	1.5mg/1ml
XANTHAN GUM	ORAL	SUSPENSION	11138662	TTV12P4NEE	13.75mg
XANTHAN GUM	ORAL	SUSPENSION, EXTENDED RELEASE	11138662	TTV12P4NEE	2.5mg/1ml
XANTHAN GUM	ORAL	SUSPENSION/ DROPS	11138662	TTV12P4NEE	2.9mg/1ml
XANTHAN GUM	ORAL	TABLET	11138662	TTV12P4NEE	14mg
XANTHAN GUM	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE	11138662	TTV12P4NEE	4mg
XANTHAN GUM	ORAL	TABLET, EXTENDED RELEASE	11138662	TTV12P4NEE	154mg
XANTHAN GUM	ORAL	TABLET, FILM COATED	11138662	TTV12P4NEE	0.08mg
XANTHAN GUM	ORAL	TABLET, FILM COATED, EXTENDED RELEASE	11138662	TTV12P4NEE	0.03mg
XANTHAN GUM	ORAL	TABLET, ORALLY DISINTEGRATING	11138662	TTV12P4NEE	0.15mg
XANTHAN GUM	ORAL	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	11138662	TTV12P4NEE	6mg
XANTHAN GUM	ORAL	TROCHE	11138662	TTV12P4NEE	63.2mg
XANTHAN GUM	RECTAL	ENEMA	11138662	TTV12P4NEE	0.25%w/v
XANTHAN GUM	RECTAL	SUSPENSION	11138662	TTV12P4NEE	0.06%w/v
XANTHAN GUM	TOPICAL	AEROSOL, FOAM	11138662	TTV12P4NEE	0.27%w/w
XANTHAN GUM	TOPICAL	CREAM	11138662	TTV12P4NEE	0.75%w/w
XANTHAN GUM	TOPICAL	GEL	11138662	TTV12P4NEE	2.85%w/w
XANTHAN GUM	TOPICAL	LOTION	11138662	TTV12P4NEE	0.3%w/v
XANTHAN GUM	TOPICAL	SUSPENSION	11138662	TTV12P4NEE	0.11%w/w
XYLITOL	BUCCAL	GUM, CHEWING	87990	VCQ006KQ1E	506.13mg
XYLITOL	ORAL	FILM, SOLUBLE	87990	VCQ006KQ1E	4.76mg
XYLITOL	ORAL	PASTE	87990	VCQ006KQ1E	1380mg/230ml
XYLITOL	ORAL	POWDER, FOR SUSPENSION	87990	VCQ006KQ1E	2000mg/15ml
XYLITOL	ORAL	SOLUTION	87990	VCQ006KQ1E	2000mg/5ml
XYLITOL	ORAL	SUSPENSION	87990	VCQ006KQ1E	333.9mg/1ml
XYLITOL	ORAL	SUSPENSION, EXTENDED RELEASE	87990	VCQ006KQ1E	450mg/1ml
XYLITOL	ORAL	TABLET	87990	VCQ006KQ1E	15.04mg
XYLITOL	ORAL	TABLET, EXTENDED RELEASE	87990	VCQ006KQ1E	85.99mg
XYLITOL	ORAL	TABLET, FILM COATED, EXTENDED RELEASE	87990	VCQ006KQ1E	72mg
XYLITOL	ORAL	TABLET, ORALLY DISINTEGRATING	87990	VCQ006KQ1E	80mg
XYLITOL	SUBLINGUAL	SPRAY	87990	VCQ006KQ1E	2.7mg/0.1ml
XYLITOL 300	ORAL	POWDER, FOR SUSPENSION		NA	0.7mg/mg
XYLITOL 300	ORAL	TABLET, ORALLY DISINTEGRATING		NA	10mg

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: January 3, 2020
Database Last Updated: January 30, 2020